INOTEK PHARMACEUTICALS CORP's ticker is ITEK and the CUSIP is 45780V102. A total of 58 filers reported holding INOTEK PHARMACEUTICALS CORP in Q1 2016. The put-call ratio across all filers is - and the average weighting 1.9%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q4 2016 | $11,281,000 | -35.7% | 1,849,300 | 0.0% | 0.14% | -28.0% |
Q3 2016 | $17,531,000 | +69.4% | 1,849,300 | +32.9% | 0.20% | +85.2% |
Q2 2016 | $10,349,000 | +0.5% | 1,391,000 | 0.0% | 0.11% | 0.0% |
Q1 2016 | $10,293,000 | +113.8% | 1,391,000 | +227.3% | 0.11% | +145.5% |
Q4 2015 | $4,815,000 | +20.5% | 425,000 | 0.0% | 0.04% | +10.0% |
Q3 2015 | $3,995,000 | – | 425,000 | – | 0.04% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Devon Park Associates, LLC | 3,243,709 | $36,751,000 | 100.00% |
RHO CAPITAL PARTNERS INC | 2,627,790 | $29,773,000 | 10.24% |
Private Capital Advisors, Inc. | 341,000 | $3,864,000 | 1.67% |
NEXTHERA CAPITAL LP | 42,000 | $476,000 | 0.68% |
SPHERA FUNDS MANAGEMENT LTD. | 360,000 | $4,079,000 | 0.60% |
SENZAR ASSET MANAGEMENT, LLC | 309,600 | $3,507,768,000 | 0.39% |
Graticule Asia Macro Advisors LLC | 148,000 | $1,676,000 | 0.27% |
FT Options LLC | 26,421 | $299,000 | 0.22% |
EAM Investors, LLC | 128,911 | $1,461,000 | 0.19% |
Tekla Capital Management LLC | 425,000 | $4,815,000 | 0.18% |